Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours-Reference-Cited by-同舟云学术

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Published:2017-07-01 Issue:1 Volume:19 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Shenouda Mira M.,Gillgrass Amy,Nham Tina,Hogg Richard,Lee Amanda J.,Chew Marianne V.,Shafaei Mahsa,Aarts Craig,Lee Dean A.,Hassell John,Bane Anita,Dhesy-Thind Sukhbinder,Ashkar Ali A.

Funder

Canadian Breast Cancer Foundation

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-017-0867-9.pdf

Reference65 articles.

1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics 2013. Special topic: liver cancer. Toronto: Canadian Cancer Society; 2013.

2. Cornejo KM, Kandil D, Khan A, Cosar EF. Theranostic and molecular classification of breast cancer. Arch Pathol Lab Med. 2014;138:44–56.

3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

4. Cadoo KA, Fornier MN, Morris PG. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns. Q J Nucl Med Mol Imaging. 2013;57:312–21.

5. Ames E, Murphy WJ. Advantages and clinical applications of natural killer cells in cancer immunotherapy. Cancer Immunol Immunother. 2014;63:21–8.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CTLA-4 Blockade of Natural Killer Cells Increases Cytotoxicity against Acute Lymphoid Leukaemia Cells;CELL J;2024

2. Resistance to Immunotherapy in Breast Cancer;Overcoming Breast Cancer Therapy Resistance;2024

3. The effect of mitochondria inhibition on natural killer cells cytotoxicity in triple-negative breast cancer cells;European Journal of Pharmacology;2023-12

4. Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment;Frontiers in Immunology;2023-11-08

5. Editorial: NK cell defects: diagnosis and treatment;Frontiers in Immunology;2023-10-31